MedPath

Clinical Performance of NIPT in Multiple Gestation Pregnancies

Completed
Conditions
Trisomy 21 in Fetus
Registration Number
NCT04488393
Lead Sponsor
University of Pennsylvania
Brief Summary

This study plans to evaluate the clinical performance of the MaterniT21 PLUS and/or GENOME Laboratory Developed Test, in the detection of fetal trisomy 21 in circulating cell-free DNA extracted from maternal blood samples obtained from women pregnant with a twin gestation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
2000
Inclusion Criteria
  • subject pregnant with a multiple gestation and received NIPT from Sequenom Laboratories;
  • subject was 18 or older at the time of NIPT
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determination of sensitivity of NIPT detection of trisomy 21 among a population of women with twin gestations.time from maternal blood draw to delivery
Determination of specificity of NIPT detection of trisomy 21 among a population of women with twin gestations.time from maternal blood draw to delivery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.